CANbridge Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
CANbridge Pharmaceuticals Inc. is publicly traded on HKSE under the ticker 1228.HK.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company focused on the global research, development, and commercialization of treatments for rare disorders and various cancer types. The company's marketed products include Hunterase, an enzyme replacement therapy for Hunter syndrome; NERLYNX (Neratinlib), a powerful, irreversible tyrosine kinase inhibitor targeting HER2-positive breast cancer; and Caphosol...
Can you invest in CANbridge Pharmaceuticals Inc.?
Yes. CANbridge Pharmaceuticals Inc. is publicly traded on HKSE under the ticker 1228.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CANbridge Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.